Showing results (261-270 of 290) with videos related to
Sort By:
Pageof 29
Med (New York, N.Y.)|April 25, 2024
Blocking cGAS-STING pathway promotes post-stroke functional recovery in an extended treatment window via facilitating remyelinationMunire Maimaiti, Chenhui Li, Mingxing Cheng, et al.Bioorganic Chemistry|October 23, 2023
X-ray crystallography study and optimization of novel benzothiophene analogs as potent selective estrogen receptor covalent antagonists (SERCAs) with improved potency and safety profilesChengfeng Bai, Yang Lv, Shuangshuang Xiong, et al.Nature Communications|January 8, 2025
Genetic code expansion reveals site-specific lactylation in living cells reshapes protein functionsChang Shao, Shuo Tang, Siqin Yu, et al.Cell Reports|January 29, 2026
Ccl12 coordinates immune-neural crosstalk to promote adipose sympathetic remodeling after burn traumaChuwei Zhang, Yanshen Chen, Jingya Guo, et al.Progress in Neurobiology|March 10, 2025
Pathogenic oligomeric Tau alters neuronal RNA processes through the formation of nuclear heteromeric amyloids with RNA-binding protein Musashi1Nicha Puangmalai, Abbigael E Aday, Madison Samples, et al.Journal of Medicinal Chemistry|February 25, 2026
Discovery of Novel and Potent Dual PARP1/ERK Inhibitors as a Promising Strategy for Cancer TherapyYing Bai, Shiqi Wu, Wenhui Zhang, et al.Neurology(R) Neuroimmunology & Neuroinflammation|June 25, 2016
Next-generation sequencing in neuropathologic diagnosis of infections of the nervous systemSteven L Salzberg, Florian P Breitwieser, Anupama Kumar, et al.Bioinformatics (Oxford, England)|April 12, 2011
Performance assessment of copy number microarray platforms using a spike-in experimentEitan Halper-Stromberg, Laurence Frelin, Ingo Ruczinski, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 12, 2016
Glycyrrhizin Protects against Acetaminophen-Induced Acute Liver Injury via Alleviating Tumor Necrosis Factor α-Mediated ApoptosisTingting Yan, Hong Wang, Min Zhao, et al.Nature Communications|May 25, 2022
Targeting dual-specificity tyrosine phosphorylation-regulated kinase 2 with a highly selective inhibitor for the treatment of prostate cancerKai Yuan, Zhaoxing Li, Wenbin Kuang, et al.Pageof 29